UK markets closed

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.17-0.81 (-3.52%)
At close: 04:00PM EDT
22.63 +0.46 (+2.07%)
After hours: 04:28PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-168,087
-152,631
-135,840
-130,466
-89,625
Depreciation & amortisation
877
849
759
558
194
Stock-based compensation
29,756
28,082
26,318
23,579
12,807
Change in working capital
10,177
7,819
-2,982
-3,224
6,384
Other working capital
-138,012
-124,992
-110,688
-105,698
-72,001
Other non-cash items
484
477
73
399
-
Net cash provided by operating activities
-137,796
-124,824
-110,062
-104,551
-69,830
Cash flows from investing activities
Investments in property, plant and equipment
-216
-168
-626
-1,147
-2,171
Purchases of investments
-531,052
-409,824
-270,655
-445,657
-320,963
Sales/maturities of investments
440,359
425,549
303,908
319,969
223,198
Net cash used for investing activities
-90,909
15,557
32,627
-126,835
-99,936
Cash flows from financing activities
Debt repayment
-
0
0
-7,250
-250
Common stock issued
239,391
93,577
24,721
0
459,335
Other financing activities
-
-
-575
-611
-
Net cash used provided by (used for) financing activities
243,152
94,783
38,565
-3,435
469,334
Net change in cash
14,447
-14,484
-38,870
-234,821
299,568
Cash at beginning of period
27,059
51,802
90,672
325,703
26,135
Cash at end of period
41,506
37,318
51,802
90,882
325,703
Free cash flow
Operating cash flow
-137,796
-124,824
-110,062
-104,551
-69,830
Capital expenditure
-216
-168
-626
-1,147
-2,171
Free cash flow
-138,012
-124,992
-110,688
-105,698
-72,001